company background image
SVS logo

Solarvest BioEnergy TSXV:SVS Stock Report

Last Price

CA$0.025

Market Cap

CA$1.5m

7D

0%

1Y

-77.3%

Updated

03 Dec, 2023

Data

Company Financials

SVS Stock Overview

Solarvest BioEnergy Inc. engages in the development of algal-based production systems to produce natural based green commercial products.

SVS fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health0/6
Dividends0/6

Solarvest BioEnergy Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Solarvest BioEnergy
Historical stock prices
Current Share PriceCA$0.025
52 Week HighCA$0.12
52 Week LowCA$0.01
Beta1.54
1 Month Change0%
3 Month Change0%
1 Year Change-77.27%
3 Year Change-72.22%
5 Year Change-86.84%
Change since IPO-92.86%

Recent News & Updates

Recent updates

Shareholder Returns

SVSCA Personal ProductsCA Market
7D0%-3.2%0.7%
1Y-77.3%-5.8%2.8%

Return vs Industry: SVS underperformed the Canadian Personal Products industry which returned -32.3% over the past year.

Return vs Market: SVS underperformed the Canadian Market which returned -0.8% over the past year.

Price Volatility

Is SVS's price volatile compared to industry and market?
SVS volatility
SVS Average Weekly Movementn/a
Personal Products Industry Average Movement9.5%
Market Average Movement8.5%
10% most volatile stocks in CA Market17.7%
10% least volatile stocks in CA Market3.2%

Stable Share Price: SVS has not had significant price volatility in the past 3 months.

Volatility Over Time: Insufficient data to determine SVS's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
2005n/an/ahttps://www.solarvest.ca

Solarvest BioEnergy Inc. engages in the development of algal-based production systems to produce natural based green commercial products. It provides human nutrition products, including omega-3; clean energy production system that enables for continuous hydrogen production; and active ingredients for human health comprising cannabinoids in algae and bone morphogenetic protein for the treatment of repairing bone fractures. Solarvest BioEnergy Inc. has a collaborative research and development agreement with FSD Pharma Inc. to produce cannabidiol (CBD), Cannabigerol (CBG), and tetrahydrocannabinol (THC) programs.

Solarvest BioEnergy Inc. Fundamentals Summary

How do Solarvest BioEnergy's earnings and revenue compare to its market cap?
SVS fundamental statistics
Market capCA$1.52m
Earnings (TTM)-CA$2.41m
Revenue (TTM)CA$984.00

1,544x

P/S Ratio

-0.6x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
SVS income statement (TTM)
RevenueCA$984.00
Cost of RevenueCA$648.00
Gross ProfitCA$336.00
Other ExpensesCA$2.42m
Earnings-CA$2.41m

Last Reported Earnings

Jul 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)-0.04
Gross Margin34.15%
Net Profit Margin-245,425.30%
Debt/Equity Ratio-97.9%

How did SVS perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.